146 related articles for article (PubMed ID: 8319997)
21. Haemodynamic, renal and hormonal responses to enalkiren in four patients with post-surgical oliguria.
Jackson B; Liu G; Perich RB; Paxton D; McNicols L; Gutteridge G; Johnston CI
Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):163-6. PubMed ID: 8039272
[TBL] [Abstract][Full Text] [Related]
22. Biochemical effects of prolonged renin inhibition in marmosets.
Wood JM; Jobber RA; Baum HP; de Gasparo M; Nussberger J
J Hypertens; 1989 Aug; 7(8):615-8. PubMed ID: 2681408
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological investigations of a new renin inhibitor in normal sodium-unrestricted volunteers.
de Gasparo M; Cumin F; Nussberger J; Guyenne TT; Wood JM; Menard J
Br J Clin Pharmacol; 1989 May; 27(5):587-96. PubMed ID: 2667598
[TBL] [Abstract][Full Text] [Related]
24. Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex.
Belz GG; Essig J; Kleinbloesem CH; Hoogkamer JF; Wiegand UW; Wellstein A
Br J Clin Pharmacol; 1988 Nov; 26(5):547-56. PubMed ID: 2974715
[TBL] [Abstract][Full Text] [Related]
25. Major role of the renin angiotensin system in the neointima formation after vascular injury in guinea pigs.
Clozel JP; Hess P; Schietinger K; Breu V; Fischli W; Baumgartner HR
Life Sci; 1994; 54(6):PL87-92. PubMed ID: 8295484
[TBL] [Abstract][Full Text] [Related]
26. Acute hypotensive responses to peptide inhibitors of renin in conscious monkeys: an effect on blood pressure independent of plasma renin inhibition.
Schaffer LW; Schorn TW; Winquist RJ; Strouse JF; Payne L; Chakravarty PK; de Laszlo SE; tenBroeke J; Veber DF; Greenlee WJ
J Hypertens; 1990 Mar; 8(3):251-9. PubMed ID: 2159506
[TBL] [Abstract][Full Text] [Related]
27. Plasma angiotensins, renin, and blood pressure during acute renin inhibition by CGP 38 560A in hypertensive patients.
Jeunemaître X; Ménard J; Nussberger J; Guyene TT; Brunner HR; Corvol P
Am J Hypertens; 1989 Nov; 2(11 Pt 1):819-27. PubMed ID: 2686709
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the effects of renin inhibition and angiotensin converting enzyme inhibition upon bradykinin potentiation.
Véniant M; Clozel JP; Fischli W
J Hypertens; 1992 Feb; 10(2):155-60. PubMed ID: 1313478
[TBL] [Abstract][Full Text] [Related]
29. Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers.
Fasanella d'Amore T; Bussien JP; Nussberger J; Waeber B; Turini GA; Brunner HR; Kler L; Francis RJ
J Cardiovasc Pharmacol; 1987 Jan; 9(1):26-31. PubMed ID: 2434790
[TBL] [Abstract][Full Text] [Related]
30. Renal and endocrine responses to a renin inhibitor, enalkiren, in normal humans.
Cordero P; Fisher ND; Moore TJ; Gleason R; Williams GH; Hollenberg NK
Hypertension; 1991 Apr; 17(4):510-6. PubMed ID: 2013477
[TBL] [Abstract][Full Text] [Related]
31. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys.
Ryan MJ; Hicks GW; Batley BL; Rapundalo ST; Patt WC; Taylor DG; Keiser JA
J Pharmacol Exp Ther; 1994 Jan; 268(1):372-9. PubMed ID: 8301578
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of enalkiren (Abbott-64662, a new renin inhibitor). I: Single dose study.
Gupta SK; Granneman GR; Boger RS; Hollenberg NK; Luther RR
Drug Metab Dispos; 1992; 20(6):821-5. PubMed ID: 1362933
[TBL] [Abstract][Full Text] [Related]
33. Angiotensinergic versus nonangiotensinergic hemodynamic effects of converting enzyme inhibition in patients with chronic heart failure. Assessment by acute renin and converting enzyme inhibition.
Kiowski W; Beermann J; Rickenbacher P; Haemmerli R; Thomas M; Burkart F; Meinertz T
Circulation; 1994 Dec; 90(6):2748-56. PubMed ID: 7994817
[TBL] [Abstract][Full Text] [Related]
34. Effects of the renin inhibitor N-[N-(3-(4-amino-1-piperidinyl-carbonyl)-2(R)-benzylpropionyl)-L- histid inyl] -(2S,3R,4S)-1-cyclohexyl-3,4-dihydroxy-6(2-pyridyl)-hexane-2-amide acetate in anesthetized rhesus monkeys.
Linz W; Heitsch H; Henning R; Jung W; Kleemann HW; Nickel WU; Ruppert D; Urbach H; Wagner A; Schölkens BA
Arzneimittelforschung; 1994 Jul; 44(7):815-20. PubMed ID: 7945514
[TBL] [Abstract][Full Text] [Related]
35. Responses to converting enzyme and renin inhibition. Role of angiotensin II in humans.
Fisher ND; Allan D; Kifor I; Gaboury CL; Williams GH; Moore TJ; Hollenberg NK
Hypertension; 1994 Jan; 23(1):44-51. PubMed ID: 8282330
[TBL] [Abstract][Full Text] [Related]
36. Renin--angiotensin antagonists and the regulation of blood pressure.
Samuels AI; Miller ED; Fray JC; Haber E; Barger AC
Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095
[TBL] [Abstract][Full Text] [Related]
37. Prolonged duration of blood pressure response to enalkiren, the novel dipeptide renin inhibitor, in essential hypertension.
Boger RS; Glassman HN; Cavanaugh JH; Schmitz PJ; Lamm J; Moyse D; Cohen A; Kleinert HD; Luther RR
Hypertension; 1990 Jun; 15(6 Pt 2):835-40. PubMed ID: 2190927
[TBL] [Abstract][Full Text] [Related]
38. Comparative studies on differential inhibition of the renin - angiotensin system in the anesthetized guinea pig.
Duan J; Jaramillo J; Jung GL; McLeod AL; Fernandes BH; Mathis D
Can J Physiol Pharmacol; 1995 Oct; 73(10):1512-8. PubMed ID: 8748944
[TBL] [Abstract][Full Text] [Related]
39. Renin inhibitors containing esters at the P2-position. Oral activity in a derivative of methyl aminomalonate.
Repine JT; Himmelsbach RJ; Hodges JC; Kaltenbronn JS; Sircar I; Skeean RW; Brennan ST; Hurley TR; Lunney E; Humblet CC
J Med Chem; 1991 Jul; 34(7):1935-43. PubMed ID: 2066966
[TBL] [Abstract][Full Text] [Related]
40. Intraocular pressure lowering effects of the renin inhibitor ABBOTT-64662 diacetate in animals.
Giardina WJ; Kleinert HD; Ebert DM; Wismer CT; Chekal MA; Stein HH
J Ocul Pharmacol; 1990; 6(2):75-83. PubMed ID: 2203852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
